Within two days after the United Kingdom officially announced that it will roll out Pfizer vaccine for the general public, Pfizer Inc's CEO Albert Bourla has said that the company is "not certain" if those who receive its vaccine will be able to transmit the coronavirus to others. In an interview in a TV channel, CEO was asked by the host in the event that he will have the option to send the contamination to others on the off chance that he is inoculated, Pfizer CEO answered that "it should be analysed". An another question by the Lester Holt in the interview, “Even though I’ve had the protection, am I still able to transmit it to other people?”. CEO replied, ''I think this is something that needs to be examined. We are not certain about that right now.'' However, Britain which is to use Pfizer under emergency condition, the Britain's Medicines and Healthcare products Regulatory Agency (MHRA), the vaccine developed by Pfizer and German biotechnology partner BioNTech, which they say is 95% effective in preventing illness, just 23 days after Pfizer published the first data from its final stage clinical trial. England has ordered for 40 million dosages of Pfizer-BioNTech's COVID-19 antibody to give the twofold portion vaccination for 20 million individuals. UK announced 'Damage Scheme' will cover COVID 19 vaccine side-effects Pfizer spirals up 5pc in share price After UK Approves Its C-Vaccine UK nods Pfizer-BioNTech vaccine for use, first in the world